EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias

Amreen Salwa iD, Alessandra Ferraresi iD, Letizia Vallino iD, Chinmay Maheshwari iD, Riccardo Moia, Gianluca Gaidano iD, Ciro Isidoro iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Amreen Salwa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale, Via P. Solaroli 17, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Glycolysis, Mitophagy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Molecular Bases of Disease Dissemination in Lymphoid Malignancies to Optimize Curative Ther-apeutic Strategies, Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy, AIL Novara Onlus, Novara, Italy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) emerges as one of the most common and fatal leukemias. Treatment of the disease remains highly challenging owing to profound metabolic rewiring mechanisms that confer plasticity to AML cells, ultimately resulting in therapy resistance. Autophagy, a highly conserved lysosomal-driven catabolic process devoted to macromolecular turnover, displays a dichotomous role in AML by suppressing or promoting disease development and progression. Glycolytic metabolism represents a pivotal strategy for AML cells to sustain increasing energy needs related to uncontrolled growth during disease progression. In this study, we tested the hypothesis that a high glycolytic rate and low autophagy flux could represent an advantage for AML cell proliferation and thus be detrimental for patient’s prognosis, and vice versa. TCGA in silico analysis of the AML cohort shows that the high expression of MAP1LC3B (along with that of BECN1 and with low expression of p62/SQSTM1) and the high expression of BNIP3 (along with that of PRKN and of MAP1LC3B), which together are indicative of increased autophagy and mitophagy, correlate with better prognosis. On the other hand, the high expression of glycolytic markers HK2, PFKM, and PKM correlates with poor prognosis. Most importantly, the association of a low expression of glycolytic markers with a high expression of autophagy–mitophagy markers conferred the longest overall survival for AML patients. Transcriptomic analysis showed that this combined signature correlates with the downregulation of a subset of genes required for the differentiation of myeloid cells, lactate/pyruvate transporters, and cell cycle progression, in parallel with the upregulation of genes involved in autophagy/lysosomal trafficking and proteolysis, anti-tumor responses like beta-interferon production, and positive regulation of programmed cell death. Taken together, our data support the view that enhanced autophagy-mitophagy flux together with low glycolytic rate predisposes AML patients to a better clinical outcome, suggesting that autophagy inducers and glucose restrictors may hold potential as adjuvant therapeutics for improving AML management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteGlycolysisMitophagyHumansPrognosisFemaleAutophagyMaleMiddle AgedBiomarkers, Tumor

Stichwörter der Autor:innen

TCGAWarburg effectautophagybioinformaticsleukemiamitochondriaoverall survivalpersonalized medicine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Molecular Pathology, Department of Health Sciences, Università del Piemonte Orientale, Via P. Solaroli 17, 28100 Novara, Italy.
  • Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Via P. Solaroli 17, 28100 Novara, Italy.

ORCID-Profile: Amreen Salwa, Alessandra Ferraresi, Letizia Vallino, Chinmay Maheshwari, Gianluca Gaidano, Ciro Isidoro

Förderung

  • Molecular Bases of Disease Dissemination in Lymphoid Malignancies to Optimize Curative Ther-apeutic Strategies
  • Associazione Italiana per la Ricerca sul Cancro Foundation Milan, Italy
  • AIL Novara Onlus, Novara, Italy
  • Molecular Bases of Disease Dissemination in Lymphoid Malignancies to Optimize Curative Therapeutic Strategies

Zitieren

APA

Salwa, A., Ferraresi, A., Vallino, L., Maheshwari, C., Moia, R., Gaidano, G., & Isidoro, C. (2024). High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111527

Vancouver

Salwa A, Ferraresi A, Vallino L, Maheshwari C, Moia R, Gaidano G, et al. High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111527

BibTeX
@article{Salwa2024,
  author = {Salwa, Amreen and Ferraresi, Alessandra and Vallino, Letizia and Maheshwari, Chinmay and Moia, Riccardo and Gaidano, Gianluca and Isidoro, Ciro},
  title = {High Mitophagy and Low Glycolysis Predict Better Clinical Outcomes in Acute Myeloid Leukemias},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111527}
}
Kostenlos starten →